Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

202270 citationsJournal Articlehybrid Open Access

Authors

NCT03031782.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 82, Issue 1, pp. 154-160

Field-Weighted Citation Impact: 10.11